Trauma-center research led by Brendan Carr of the School of Medicine is highlighted.
Perelman School of Medicine
Lynn Schuchter of the School of Medicine comments on a drug treatment that was shown to extend skin-cancer patients’ lives.
Oren Friedman of the School of Medicine is interviewed about why several men are opting for cosmetic surgery.
Robert Vonderheide of the School of Medicine leads a study on treating pancreatic cancer.
Researchers at the University of Pennsylvania’s Abramson Cancer Center have discovered a novel way of treating pancreatic cancer by activating the immune system to destroy the cancer’s scaffolding. The strategy was tested in a small cohort of patients with advanced pancreatic cancer, several of whose tumors shrank substantially. The team believes their findings – and the novel way in which they uncovered them -- could lead to quicker, less expensive cancer drug development.